Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
- 4 resultaten
Zoekresultaten
-
2020
High total metabolic tumor volume on 18F-FDG-PET/CT correlates with lack of immune response in advanced melanoma patients treated with pembrolizumab.
Gondry, O., Awada, G., Özdemir, I., Schwarze, J. K., Daeninck, E., Jansen, Y., Seremet, T., Goethals, L., Everaert, H., Neyns, B. & Keyaerts, M., 15 jan 2020, (Unpublished).Onderzoeksoutput: Poster
-
2018
Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Awada, G., Özdemir, I., Schwarze, J. K., Daeninck, E., Gondry, O., Jansen, Y., Caplanusi, T., Keyaerts, M., Everaert, H. & Neyns, B., 13 dec 2018.Onderzoeksoutput: Poster
-
Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
Awada, G., Özdemir, I., Schwarze, J. K., Daeninck, E., Gondry, O., Jansen, Y., Caplanusi, T., Keyaerts, M., Everaert, H. & Neyns, B., 15 dec 2018, In: Annals of Oncology. 29, suppl_10, 21P.Onderzoeksoutput: Meeting abstract (Journal)
Bestand92 Downloads (Pure) -
Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab
Gondry, O., Özdemir, I., Jansen, Y., Awada, G., Goethals, L., Schwarze, J. K., Seremet, T., Everaert, H., Neyns, B. & Keyaerts, M., 19 okt 2018.Onderzoeksoutput: Unpublished abstract